As of May 27
| +0.06 / +1.52%|
The 1 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +149.38% increase from the last price of 4.01.
The current consensus among 1 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.